KCM
CLVS

Kennedy Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Kennedy Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50,807
Closed -$3.46M – 774
2017
Q4 		$3.46M Buy
50,807
+24,027
+90% +$1.68M 0.06% 531
2017
Q3 		$2.21M Sell
26,780
-15,529
-37% -$1.23M 0.04% 601
2017
Q2 		$3.96M Buy
+42,309
New +$2.59M 0.08% 471

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Kennedy Capital Management's CLVS Position: Q1 2018 in Review

Kennedy Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2018, closing a stake of 50,807 shares — an estimated $3.46M sold.

Kennedy Capital Management first reported a position in CLVS in Q2 2017 and held it in 3 quarters. The position peaked at $3.96M in Q2 2017. 229 funds tracked by Wall St. Rank hold CLVS as of Q1 2018.

  • Kennedy Capital Management reported no remaining Clovis Oncology, Inc. position as of Q1 2018 after selling out during the quarter.
  • Kennedy Capital Management sold 50,807 Clovis Oncology, Inc. shares in Q1 2018, an estimated $3.46M.
  • Kennedy Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 3 quarters.
  • Kennedy Capital Management's Clovis Oncology, Inc. position peaked at $3.96M in Q2 2017.
  • 229 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2018.

Based on Kennedy Capital Management's 13F filing for Q1 2018, filed 14 May 2018.